Top Qs
Timeline
Chat
Perspective
Etrasimod
Medication From Wikipedia, the free encyclopedia
Remove ads
Etrasimod, sold under the brand name Velsipity, is a medication that is used for the treatment of ulcerative colitis.[6] It is a selective sphingosine-1-phosphate (S1P) receptor modulator that modifies the activity of the immune system.[6] It is taken by mouth.[6]
The most common side effects include lymphopenia (low levels of lymphocytes) and headache.[8]
Etrasimod was discovered by Arena Pharmaceuticals, with subsequent development by Pfizer.[10] Etrasimod was approved for medical use in the United States in October 2023,[6] and in the European Union in February 2024.[8]
Remove ads
Medical uses
Etrasimod is used for the treatment of moderate to severe ulcerative colitis.[6][8]
Mechanism of action
It works by causing T cells to become trapped in the lymph nodes, preventing them from entering the bloodstream, from where they would travel to other tissues in the body and mediate inflammation.[11][12][13][14][15][16]
Society and culture
Legal status
Velsipity was approved by the US Food and Drug Administration (FDA) in October 2023.[6][17][18]
In December 2023, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion, recommending the granting of a marketing authorization for the medicinal product Velsipity, intended for the treatment of ulcerative colitis.[8] The applicant for this medicinal product is Pfizer Europe MA EEIG.[8] Etrasimod was approved for medical use in the European Union in February 2024.[8]
Names
Etrasimod is the international nonproprietary name.[19]
References
Wikiwand - on
Seamless Wikipedia browsing. On steroids.
Remove ads